Vaccine Confidence Project
The Vaccine Confidence Project is a non-profit research center at the London School of Hygiene & Tropical Medicine, founded in 2010 by Professor Heidi Larson. It operates the Vaccine Confidence Index across 150+ countries and serves governments, WHO, UNICEF, and public health bodies with research, advisory, and AI-enabled misinformation tools.
- Company typePrivate
- Founded2010
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Vaccine Confidence Project does
The Vaccine Confidence Project (VCP) is a non-profit academic research organization founded in 2010 by Professor Heidi Larson at the London School of Hygiene & Tropical Medicine (LSHTM). It is the first and only research group fully dedicated to mapping and monitoring public confidence in vaccination at a global scale, and was designated a World Health Organization Centre of Excellence on addressing Vaccine Hesitancy. VCP's core product is the Vaccine Confidence Index (VCI), a global monitoring and mapping tool that tracks public confidence in vaccination across more than 150 countries since 2015 using survey data, social media surveillance, and qualitative methods, delivered through interactive maps and data visualizations. The organization also delivers research services (mixed-methods studies on drivers of vaccine hesitancy), advisory and briefing products for public health communicators, AI-enabled fact-checking tools (chatbots, real-time dashboards, browser extensions targeting HPV and COVID-19 vaccine misinformation), and academic publications.
VCP operates as a research center within LSHTM and does not sell commercial products. Revenue is generated through institutional research grants and project-based funding from governments and international organizations, complemented by targeted partnerships with pharmaceutical companies (e.g., GlaxoSmithKline) and philanthropic funders (e.g., Wellcome Trust, UK NIHR, UK FCDO). Its go-to-market is community-led, relying on peer-reviewed publications, policy reports, the public Vaccine Confidence Index map, media commentary, podcasts, webinars, and direct advisory engagement with WHO, UNICEF, ECDC, Gavi, and national governments. Customers are segmented into governments and policymakers (primary), international health organizations, healthcare professionals, and the general public. Operations are anchored in London, with a European regional office at the University of Antwerp established in 2019.
Vaccine Confidence Project firmographics
Firmographics- Name
- Vaccine Confidence Project
- Legal name
- The Vaccine Confidence Project™
- Website
- https://vaccineconfidence.org
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- The Vaccine Confidence Project is a non-profit research center at the London School of Hygiene & Tropical Medicine, founded in 2010 by Professor Heidi Larson. It operates the Vaccine Confidence Index across 150+ countries and serves governments, WHO, UNICEF, and public health bodies with research, advisory, and AI-enabled misinformation tools.
- Ownership category
- akta.pro rank
Vaccine Confidence Project industry classification
Industry- Product category
- Vaccine Confidence Research
- NAICS
- Marketing Research and Public Opinion Polling (541910)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Vaccine Policy, Advisory Committees & Program Governance (HLAJAHAJ)
- akta.pro secondary industries
- Immunization & Vaccine Delivery Programs (BPADAIAB), Vaccine Coverage Assessment, Reminder/Recall & Demand Generation (HLAJAHAH)
Keywords
Where Vaccine Confidence Project is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Vaccine Confidence Project business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Institutional Research Funding: The VCP operates as a research center within the London School of Hygiene & Tropical Medicine, funded through institutional research grants, project-based funding from governments and international organizations, and partnerships with pharmaceutical companies for specific research initiatives
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Vaccine Confidence Project product offering
Product offeringCore offering
The Vaccine Confidence Project is a non-profit academic research organization that conducts global research on vaccine confidence, mapping public attitudes toward vaccination across 150+ countries through the Vaccine Confidence Index and mixed-methods studies. It produces policy reports, briefings, and guidance for governments and international health organizations, and develops AI-powered tools (chatbots, fact-checking extensions, real-time dashboards) to counter vaccine misinformation. The organization operates as a WHO Centre of Excellence on addressing Vaccine Hesitancy and provides advisory services to support immunization policy and intervention design.
Product overview
The Vaccine Confidence Project (VCP) is a research organization established in 2010 by Professor Heidi Larson at the London School of Hygiene & Tropical Medicine. It operates as a platform of research services and advisory offerings rather than a unified software product. The core offering is the Vaccine Confidence Index (VCI), which maps and monitors global vaccine confidence across 150+ countries through surveys and data visualization. VCP's portfolio includes research projects examining vaccine confidence drivers and barriers, publications and reports (including the bi-annual State of Vaccine Confidence in the EU), practical briefings and guidance for public health communicators, and AI-powered tools for misinformation detection including chatbots, fact-checking extensions, and real-time dashboards. The organization serves as a WHO Centre of Excellence on addressing Vaccine Hesitancy and works with governments, international organizations, and healthcare institutions to support policy and intervention design.
Differentiator
Problem solved
Functional benefit
Brands
- Vaccine Confidence Index (VCI): Global mapping and monitoring tool for public confidence in vaccination across countries
Products and services
- Vaccine Confidence Index (VCI) A global monitoring and mapping tool that tracks public confidence in vaccination across countries over time, providing interactive maps and data visualizations of vaccine confidence trends. Used by governments, international health organizations, and researchers to identify critical global trends in vaccine confidence.
- Briefings & Guidance Publications Practical guidance documents providing evidence-based advice for public health programme managers and communicators involved with immunisation services on addressing vaccine hesitancy. Aimed at decision-makers and immunisation stakeholders in the UK and internationally.
- State of Vaccine Confidence in the EU Reports Bi-annual reports tracking vaccine confidence trends across the EU, monitoring public attitudes to vaccines and examining changes over time through systematic research. Used by EU policymakers, public health agencies, and researchers.
- Data Visualisations Interactive data visualizations showing global trends in vaccine confidence, country-level data, and mapping of public attitudes to vaccination over time. Published for use by researchers, policymakers, and the public.
- Vaccine Confidence in Europe Research Mixed-methods research examining vaccine confidence in general populations and among healthcare professionals in Eastern Europe and Central Asia, including assessments of confidence in MMR, HPV, influenza, and COVID-19 vaccines. Commissioned by UNICEF and partners for policy and training purposes.
- Risk Perceptions and Acceptance Study Study examining psychosocial factors influencing COVID-19 and influenza vaccine confidence and acceptance across France, Hungary, and Italy using surveys and qualitative interviews. Funded by GlaxoSmithKline.
- The Bambisana Study Mixed-methods study testing effectiveness of tailored, context-specific education and community engagement including social media interventions to increase influenza vaccination uptake among youth in Soweto, South Africa.
- Fact-checking AI Suite AI-powered interventions including fact-checking extensions, real-time dashboards, and chatbots designed to debunk misinformation and improve HPV vaccine acceptance in Japan, Korea, and China.
Quantifiable outcome
- Research coverage spans 150+ countries covering almost 80% of the world population
Companies that use Vaccine Confidence Project
Customer profileSegments4 records
Ideal customer profiles3 records
Vaccine Confidence Project technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature2 records
Vaccine Confidence Project partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- UNICEFcorePartnership with UNICEF Regional Office for Europe and Central Asia (ECARO) to address vaccine hesitancy among health workers and strengthen national training curricula in countries including Azerbaijan, Georgia, Kyrgyzstan, Montenegro, North Macedonia, Republic of Moldova, Romania, and Uzbekistan
- Wits VidacoreResearch partnership for the Bambisana Study examining influenza vaccination among youth in Soweto, South Africa, testing social media and community influencer strategies to increase vaccine uptake
- PHRU (Perinatal HIV Research Unit)coreResearch partner in South Africa for the Bambisana Study on influenza vaccination among youth in Soweto
- Fiocruz (Oswaldo Cruz Foundation)coreResearch partner in Brazil for Zika virus social and economic impact study, providing local expertise and infrastructure
- London School of Hygiene & Tropical MedicinecoreHost institution for the Vaccine Confidence Project, providing academic infrastructure, research resources, and institutional credibility
- European Centre for Disease Prevention and Control (ECDC)coreCollaboration on understanding vaccine hesitancy in Europe, particularly among healthcare workers, including HPV vaccine hesitancy research
- FreshNowminorMarketing partner for the Bambisana Study campaign supporting influenza vaccination awareness in South Africa
- Laboratory of Data Discovery for Health (D24H) at Hong Kong UniversitycoreTechnology partner for AI-based fact-checking interventions to tackle HPV vaccine misinformation in Japan, Korea, and China
- Global Listening ProjectcoreSister organization collaboration on societal preparedness research, including a 70-country societal preparedness index with the Center for Trusted Internet & Community at National University of Singapore
- World Health Organization (WHO)coreFormal designation as WHO Centre of Excellence on addressing Vaccine Hesitancy; collaboration on SAGE Working Group on vaccine hesitancy and Western Pacific Region initiatives
- Gavi, the Vaccine AlliancecoreCollaborated through Gavi's Advocacy Task Force, chaired by VCP Founder Professor Heidi Larson
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
Vaccine Confidence Project competitors and assessment
Company assessmentBroad incumbents
- Wellcome Trust: A large, established global health foundation funding research across infectious disease, mental health, and public engagement, including VCP's Zika work. Comparable as a broader incumbent funder in the same vaccine confidence research space with deeper resources and a wider portfolio.
- London School of Hygiene & Tropical Medicine: VCP's parent academic institution; a globally prominent public health research university. Comparable as a broader incumbent providing the academic infrastructure under which VCP operates and conducting adjacent immunization and policy research.
- Harvard T.H. Chan School of Public Health: Major academic public health institution producing influential vaccine policy and hesitancy research. Comparable as a broader incumbent peer in public health research with deeper resources but a less specialized focus on vaccine confidence monitoring.
- Africa CDC: Continental public health agency coordinating immunization strategy and vaccine hesitancy response in Africa. Comparable as a peer entity working on vaccine confidence and uptake in the regions where VCP also researches (e.g., Soweto study).
Direct peers
- Sabin Vaccine Institute: A global nonprofit that advances vaccine access and uptake through research, advocacy, and capacity-building, including work on vaccine acceptance and immunization policy. Highly comparable to VCP as a mission-aligned research and advisory organization focused on immunization demand and confidence.
- Vaccine Confidence Fund: A dedicated funder supporting research and interventions on vaccine confidence globally. Directly comparable to VCP because both operate in the same niche of funding and producing vaccine confidence research, with overlapping researcher networks.
- Vaccinate Your Family: US-based nonprofit advocating for vaccine confidence and access across the lifespan. Comparable as a peer organization focused on improving vaccine confidence and addressing hesitancy through public engagement and education.
- Centre for Evaluation of Vaccination (University of Antwerp): Hosts the European regional office of VCP and conducts vaccine hesitancy and coverage research. Directly comparable as a peer academic research group operating in vaccine confidence and evaluation with shared methodology and overlapping staff.
Others
- Reuters Institute for the Study of Journalism (Oxford): Researches media trust and misinformation including health information ecosystems. Adjacent peer because both study public information environments and trust in authoritative sources, themes central to VCP's work.
Emerging players
- Chatham House Centre for Global Health Security: Think tank producing research and convening on global health security, including pandemic preparedness and vaccine policy. Adjacent peer because it covers overlapping themes of vaccine governance, hesitancy, and global health policy.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Vaccine Confidence Project social profiles
Digital presenceVaccine Confidence Project financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vaccine Confidence Project leadership team
Management profileNumber of profiles
Profiles4 records
Vaccine Confidence Project funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vaccine Confidence Project M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vaccine Confidence Project
What does Vaccine Confidence Project do?
The Vaccine Confidence Project is a non-profit academic research organization that conducts global research on vaccine confidence, mapping public attitudes toward vaccination across 150+ countries through the Vaccine Confidence Index and mixed-methods studies. It produces policy reports, briefings, and guidance for governments and international health organizations, and develops AI-powered tools (chatbots, fact-checking extensions, real-time dashboards) to counter vaccine misinformation. The organization operates as a WHO Centre of Excellence on addressing Vaccine Hesitancy and provides advisory services to support immunization policy and intervention design.
Is Vaccine Confidence Project a public or private company?
Vaccine Confidence Project is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Vaccine Confidence Project founded?
Vaccine Confidence Project was founded in 2010. It employs 1 to 10 people.
Where is Vaccine Confidence Project based?
Vaccine Confidence Project is headquartered in London, United Kingdom, in the Europe region.
How does Vaccine Confidence Project make money?
One revenue line is on record: institutional Research Funding.
Who are Vaccine Confidence Project's main competitors?
Broad incumbents on record are Wellcome Trust, London School of Hygiene & Tropical Medicine, Harvard T.H. Chan School of Public Health and Africa CDC. Direct peers are Sabin Vaccine Institute, Vaccine Confidence Fund, Vaccinate Your Family and Centre for Evaluation of Vaccination (University of Antwerp). Reuters Institute for the Study of Journalism (Oxford) is listed as an others. Chatham House Centre for Global Health Security is listed as an emerging player.
Does Vaccine Confidence Project have an API?
No public API is recorded for Vaccine Confidence Project.
What industry is Vaccine Confidence Project in?
Vaccine Confidence Project's product category is Vaccine Confidence Research. Its primary akta.pro industry code is HLAJAHAJ, Vaccine Policy, Advisory Committees & Program Governance, with a secondary code of BPADAIAB, Immunization & Vaccine Delivery Programs. Its NAICS code is 541910 and its SIC code is 8731.